Recurrent B-Cell Non-Hodgkin Lymphoma

general

The reemergence of B-cell non-Hodgkin lymphoma after a period of remission.

31

Centers

38

Active Trials

$1.2B

Cancer Funding

Specific Cancer Types(1)

Top Centers for Recurrent B-Cell Non-Hodgkin Lymphoma(31)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
High-Volume Research Center
72.7
2
High-Volume Research Center
72.7
3
NCI Comprehensive
Active Research Program
68.8
4
NCI Comprehensive
Active Research Program
68.8
5
Active Research Program
68.8
6
NCI Comprehensive
Active Research Program
50.9
7
NCI Comprehensive
Active Research Program
50.9
8
NCI Comprehensive
Active Research Program
50.9
9
NCI Comprehensive
Active Research Program
50.9
10
NCI Comprehensive
Active Research Program
50.9
1150.9
12
NCI Comprehensive
Active Research Program
50.9
13
NCI Comprehensive
Active Research Program
50.9
14
NCI Comprehensive
Active Research Program
50.9
15
NCI Comprehensive
Active Research Program
50.9
16
NCI Comprehensive
Active Research Program
50.9
17
NCI Comprehensive
Active Research Program
50.9
18
NCI Comprehensive
Active Research Program
50.9
19
NCI Comprehensive
Active Research Program
50.9
20
NCI Comprehensive
Active Research Program
50.9
21
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
50.9
22
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
50.9
23
NCI Comprehensive
Active Research Program
50.9
24
Active Research Program
50.9
25
Active Research Program
50.9
26
NCI Comprehensive
32.3
27
NCI Comprehensive
32.3
28
NCI Comprehensive
32.3
2932.3
30
NCI Comprehensive
31
NCI Comprehensive

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →